ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
TScan Therapeutics Inc

TScan Therapeutics Inc (TCRX)

4.26
0.32
(8.12%)
Closed 25 November 8:00AM
4.26
0.00
(0.00%)
After Hours: 10:00AM

TScan Therapeutics Inc Financial Summary

The current TCRX market cap is 227.36M. The company's latest EPS is USD -1.6717 and P/E is -2.55.

Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 3.15M3.89M7.21M566k536k
Operating Income -24.61M-24.75M-21.36M-31.37M-34.11M
Net Income -24.05M-23M-19.61M-30.14M-31.66M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 01.09M10.14M13.54M21.05M
Operating Income -14.21M-26.23M-48.64M-66.64M-93.46M
Net Income -13.66M-26.23M-48.63M-66.22M-89.22M
Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 316.92M291.38M272.15M240.83M374.87M
Total Liabilities 126.32M122.42M121.28M117.87M119.65M
Total Equity 190.61M168.96M150.87M122.97M255.22M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 49.38M49.74M188.11M199.09M272.15M
Total Liabilities 6.84M32.52M27.33M99.66M121.28M
Total Equity -17.14M-42.46M160.78M99.43M150.87M
Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -45.61M-37.59M-61.36M-29.27M-55.49M
Investing -1.26M-62.67M-60.76M36.16M2.45M
Financing 135.68M135.42M135.44M258k161.85M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -12.52M-3.02M-48.68M-66.5M-61.36M
Investing -1.25M-4.24M-9.94M-4.23M-60.76M
Financing 34.81M288k189.67M29.36M135.44M
Market Cap 227.36M
Price to Earnings Ratio -2.55
Price to Sales Ratio 10.8
Price to Cash Ratio 1.7
Price to Book Ratio 1.51
Dividend Yield -

Share Statistics

Shares Outstanding 53.37M
Average Volume (1 week) 202.4k
Average Volume (1 Month) 270.25k
52 Week Change 3.15%
52 Week High 9.69
52 Week Low 3.73
Spread (Intraday) 1.72 (28.96%)

Company Info

Company Name TScan Therapeutics Inc
Address 3500 s dupont hwy
dover, delaware 19901
Website https://www.tscan.com
Industry biological pds,ex diagnstics (2836)